Hepatic Intra-Arterial Administration of Ipilimumab in Combination With Intra-venous Nivolumab for Advanced Hepatocellular Carcinoma
Clinical trial NCT04823403 · UNKNOWN
Trial details
- NCT number
- NCT04823403
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-13
- Primary completion
- 2022-11-04
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.